Finasteride Treatment of Severe Nodulocystic Acne
NCT02502669
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
106
Enrollment
INDUSTRY
Sponsor class
Conditions
NODULOCYSTIC ACNE
Interventions
DRUG:
Finasteride 23.5 mg tablets
DRUG:
Finasteride 33.5 mg tablets
DRUG:
Placebo tablets
Sponsor
Elorac, Inc.